UBM Announces Content for 10th Annual Japanese Pharma & Bio Events

AMSTERDAM, March 8, 2011 - Leading events organiser UBM Live (www.ubmlive.com) and its sister
company, UBM Japan Co. Ltd. (www.ubmjapan.com/corp/en/index.html),
today announced details of the anticipated content and new developments
taking place at the tenth anniversary of CPhI Japan, a leading International
pharmaceutical event, being held from 18-20 April, 2011 at the Big Sight
Exhibition Center in Tokyo. The full line-up of events surrounding CPhI Japan
includes P-MEC Japan, which covers Pharma machinery and equipment, ICSE
Japan, which looks at outsourcing solutions, and BioPh Japan, which showcases
the biopharma sector. Attendance to the shows is free through
pre-registration at www.cphijapan.com.

One significant development this year is that, based on the positive
feedback received for the 2010 BioPh Pavilion, BioPh is to be introduced as a
stand-alone event focusing on the increasing convergence of pharma and
biotech business models in global healthcare. It will feature exhibitors in
areas such as bioinformatics, diagnostics, genomics and proteomics, and
process validation. CPhI Japan's other co-located shows, ICSE and P-MEC, have
also shown healthy growth in popularity and size since their introductions in
2005 and 2008 respectively, and expect to continue this upwards trend in
2011.

"The response from exhibitors and attendees to the BioPh Pavilion was
excellent and the interest generated last year has proven strong enough to
expand into a dedicated event," commented Haf Cennydd, Event Director of
ICSE/P-MEC/BioPh Japan. "It's also very pleasing to see that both ICSE Japan
and P-MEC Japan have flourished and built a reputation as being key meeting
places for pharma expertise. We are expecting strong turnouts for the events
once again in 2011. Much of this growth can be attributed to the developments
in the Japanese generic drug market. Manufacturers in this industry are
currently keen to establish stable sources for APIs, and companies that can
provide such sources with the right quality and appropriate price points will
be at the events to promote their products and services. The rich networking
platform and 'matchmaking' opportunities that our Japanese shows provide are
reflected in the positive growth in their popularity. It's a win-win
situation for all parties."

In celebration of CPhI Japan's ten year anniversary, an extensive seminar
program featuring more than 120 sessions to be held over the three-day
period. Attendees from each show will have the option to attend one of the
many sessions where speakers will cover the most current and relevant topics
in the industry. Topics include: significant developments for the
pharmaceutical industry in Japan in 2010; pricing system reform for
innovative drugs; improvements in drug approvals; and, the importance of the
pharmaceutical industry as a driver of economic growth. Special seminars
organized by the Japan Pharmaceutical Manufacturers Association (JPMA) will
present issues such as quality assurance in the supply chain and the
developments of biologics. More details of the seminars content can be found
at www.cphijapan.com.

After a successful introduction in 2010, a special workshop, "A Practical
Guideline to the Revised Pharmaceutical Affairs Law," will once again be
hosted for International guests. Participants of the workshop will have the
chance to ask questions about the pharmaceuticals affairs laws directly to
the officials taking part in the workshop. Questions will be invited on,
amongst other subjects, the maintenance of Master File Systems for drug
substances, the accreditation processing of foreign manufacturers, the
application for GMP Compliance, inspection procedures for foreign
manufacturers.

"CPhI Japan's appeal is global, and the Japanese pharma market's steady
track record of growth and progress has contributed to CPhI Japan's global
appeal. It has become known as a global meeting place where attendees can
find major suppliers of quality pharmaceutical ingredients under one roof,"
commented Annemieke Timmers, CPhI Brand Director at UBM Live. "Specifically,
Japan is the second largest pharma market after the US and accounted for
approximately 11% of the world market in 2010, around $US60 billion in
revenue and Japan's generic drug sector is expected to triple by 2012(1). IMS
Health forecasts that the Japanese pharmaceutical market will increase to
$US79 billion within five years and nearly double to $US105 billion by
2023(1)."

UBM Live's combined CPhI Japan 2010 events saw over 450 exhibitors from
29 countries despite the air travel disruptions caused by the Icelandic
volcanic eruption. Even with the travel setbacks, CPhI Japan grew 5.2%
between 2009 and 2010; it was attended by over 14,000 visitors. Further
reflecting the truly global nature of the events, CPhI Japan will host
national pavilions for Italy, China, Korea, the UK ,Spain and India, JBPMA,
while formal supporters of the event include Japan's Ministry of Health,
Labour and Welfare, the Ministry of Economy, Trade and Industry ,trade
associations and industry organisations.

Further information is available (including an offer for free attendance
through pre-registration) at www.cphijapan.com. Further information
about the co-located events can be found online at: www.icsejapan.com,
www.bioph-japan and www.pmec-japan.com. For more information on
other global events, please visit us online at: www.cphi-sa.com,
www.cphi-india.com, www.cphi-china.com or www.cphi.com.

(1) Sources:

www.leaddiscovery.co.uk/reports/236/Japanese_Pharmaceutical_Market_20062011/

www.bioportfolio.com/cgi-bin/acatalog/The_Japanese_Pharmaceutical_Market_2008-2023.html

https://www.espicom.com/Prodcat.nsf/Search/00000352?OpenDocument

www.echinachem.com/EN/News/0907/2009771128393431.shtml

www.ims-japan.co.jp/industry_trends_top_line_information.php

Notes for Editors:

- With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live
operates a number of market leading exhibitions, awards, websites/online
products and publications in twenty different business sectors. UBM Live is
part of UBM Ltd, a leading global media company listed on the London Stock
Exchange. See www.ubmlive.com

- UBM Ltd is a leading global business media company. We inform markets
and bring the world's buyers and sellers together at events, online, in print
and provide them with the information they need to do business successfully.
Our 6,000 staff in more than 30 countries are organised into specialist teams
that serve these communities, helping them to do business and their markets
to work effectively and efficiently. See www.ubm.com

Impress PR, Global (excl. North America): Richard Kerns, richard at impress-pr.com, +44-161-728-5880; North America: Beth Willers, beth at impress-pr.com, +1-503-928-7828; UBM Live, Rob Sahi (CPhI), +31-20-40-99-5561 or Ian O'Malley (ICSE, P-MEC, BioPh), +31-20-40-99-5526